M0
Showing 26 - 50 of >10,000
Hemangioma, Kaposiform Hemangioendothelioma Trial in Shanghai (Sirolimus(0.8mg/m2), Sirolimus(0.7mg/m2))
Completed
- Hemangioma
- Kaposiform Hemangioendothelioma
-
Shanghai, ChinaChildren's Hospital of Fudan University
Jan 27, 2023
Healthy Women of Child Bearing Potential Trial (R21/Matrix-M1, Saline and R21/Matrix-M1, Sterile isotonic (0.9%) normal saline)
Not yet recruiting
- Healthy Women of Child Bearing Potential
- R21/Matrix-M1
- +2 more
- (no location specified)
Oct 10, 2023
Pancreas Adenocarcinoma Trial in Detroit, Milwaukee (CPI-613® (Dose level -1.0 250 mg/m^2), CPI-613® (Dose level 1.0 500
Recruiting
- Pancreas Adenocarcinoma
- CPI-613® (Dose level -1.0 250 mg/m^2)
- +6 more
-
Detroit, Michigan
- +1 more
Nov 9, 2022
Mental Health Trial in Manchester (Single-Session Method of Levels Intervention)
Not yet recruiting
- Mental Health
- Single-Session Method of Levels Intervention
-
Manchester, Greater Manchester, United Kingdom
- +1 more
Sep 25, 2023
Radiotherapy After Primary Chemotherapy for Breastcancer
Completed
- Breast Cancer
- radiation - no radiation see intervention description
- radiation: see intervention description
-
Tilburg, Brabant, Netherlands
- +5 more
Oct 11, 2022
Prostate Cancer Trial in Denmark, Finland, Norway (radiation, other, drug)
Recruiting
- Prostate Cancer
- Radiotherapy or surgery
- +2 more
-
Copenhagen, Denmark
- +10 more
Dec 22, 2022
Influenza, Human, Vaccination; Infection, Vaccines Trial in Saint Petersburg (Flu-M, Inactivated split influenza vaccine 0.5 mL,
Completed
- Influenza, Human
- +2 more
- Flu-M, Inactivated split influenza vaccine 0.5 mL
- +3 more
-
Saint Petersburg, Russian Federation
- +1 more
Jul 19, 2022
Nicotine Vaping, Nicotine, Vaping Trial in High Point (CA35, CM35, Cig)
Completed
- Nicotine Vaping
- +2 more
- CA35
- +2 more
-
High Point, North CarolinaHigh Point Clinical Trials Center (HPCTC)
Aug 30, 2022
Prostate Cancer Trial in Baltimore (18F-DCFPyL Injection)
Withdrawn
- Prostate Cancer
- 18F-DCFPyL Injection
-
Baltimore, MarylandJohns Hopkins University
Dec 14, 2021
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic
Completed
- Adult Acute Megakaryoblastic Leukemia (M7)
- +15 more
- trebananib
- +3 more
-
Buffalo, New York
- +1 more
Sep 8, 2022
Malignant Melanoma Trial in Kansas City (Wide Local Excision)
Completed
- Malignant Melanoma
- Wide Local Excision
-
Kansas City, KansasUniversity of Kansas Medical Center
Apr 29, 2021
Developmental Language Disorder, Language Delay, Language Development Trial in Oshawa, Toronto (Intervention to address late
Recruiting
- Developmental Language Disorder
- +2 more
- Intervention to address late talking
-
Oshawa, Ontario, Canada
- +1 more
Dec 4, 2023
Pyoderma, Pyoderma Gangrenosum, Pyoderma Vegetans Trial in Minsk, Riga (Monoclonal antibody (Mab) sB24M)
Active, not recruiting
- Pyoderma
- +3 more
- Monoclonal antibody (Mab) sB24M
-
Minsk, Belarus
- +1 more
Jul 8, 2022
Atherosclerotic Cardiovascular Disease, Atherosclerotic Cardiovascular Disease Risk Equivelents, Elevated Low Density
Active, not recruiting
- Atherosclerotic Cardiovascular Disease
- +2 more
- Inclisiran
- Behavioural Support
-
Sale, Cheshire, United Kingdom
- +16 more
Jan 20, 2023
Malignant Melanoma Trial in Amsterdam (Tilsotolimod, Saline (0.9% sodium chloride))
Recruiting
- Malignant Melanoma
- Tilsotolimod
- Saline (0.9% sodium chloride)
-
Amsterdam, NetherlandsVU Medical Centere
Apr 14, 2021
Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7) Trial in Atlanta,
Terminated
- Adult Acute Basophilic Leukemia
- +16 more
- eltrombopag olamine
- standard follow-up care
-
Atlanta, Georgia
- +1 more
Jul 20, 2022
Wound Complication Trial in New York, Toronto (Prevena, Aquacel)
Completed
- Wound Complication
- Prevena
- Aquacel
-
New York, New York
- +2 more
Mar 7, 2022
Kidney Transplant Recipients Trial in Toronto (Dapagliflozin 10 MG, Semaglutide, 1.0 mg/mL)
Not yet recruiting
- Kidney Transplant Recipients
- Dapagliflozin 10 MG
- Semaglutide, 1.0 mg/mL
-
Toronto, Ontario, CanadaToronto General Hospital
Jul 6, 2023
Nicotine, Vaping, Nicotine Vaping Trial in Belfast (P4M3 CA35, P4M3 CM35, CIG)
Recruiting
- Nicotine
- +2 more
- P4M3 CA35
- +3 more
-
Belfast, United KingdomCelerion
Aug 3, 2022
Postoperative Pain, Acute Trial in Zagazig (25 ml of bupivacaine 0.25% via serratus anterior block, 25 ml of bupivacaine 0.25%
Recruiting
- Postoperative Pain, Acute
- 25 ml of bupivacaine 0.25% via serratus anterior block
- 25 ml of bupivacaine 0.25% via modified serratus anterior palne block
-
Zagazig, EgyptHeba M Fathi
Dec 21, 2022
Obesity, Bariatric Surgery Candidate, Mental Health Disorder Trial in Ottawa, Thunder Bay, Toronto (Tele-CBT, Self-Help
Not yet recruiting
- Obesity
- +3 more
- Tele-CBT
- Self-Help Resources
-
Ottawa, Ontario, Canada
- +3 more
May 17, 2022
Pharmacokinetics Trial in Oslo (GE200486 0.5M Injection)
Completed
- Pharmacokinetics
- GE200486 0.5M Injection
-
Oslo, NorwayRikshospitalet
Dec 29, 2022